EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 142 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,451,680 | -8.2% | 432,000 | 0.0% | 1.06% | +60.2% |
Q2 2023 | $3,758,400 | +166.3% | 432,000 | -10.0% | 0.66% | +126.0% |
Q1 2023 | $1,411,200 | -16.0% | 480,000 | 0.0% | 0.29% | -19.3% |
Q4 2022 | $1,680,000 | -55.8% | 480,000 | 0.0% | 0.36% | -59.1% |
Q3 2022 | $3,797,000 | +0.5% | 480,000 | 0.0% | 0.88% | -12.1% |
Q2 2022 | $3,778,000 | -35.2% | 480,000 | 0.0% | 1.01% | -31.4% |
Q1 2022 | $5,832,000 | -0.7% | 480,000 | 0.0% | 1.47% | +28.8% |
Q4 2021 | $5,875,000 | +25.3% | 480,000 | +6.7% | 1.14% | +54.9% |
Q3 2021 | $4,689,000 | +15.9% | 450,000 | 0.0% | 0.74% | +47.5% |
Q2 2021 | $4,046,000 | -11.5% | 450,000 | 0.0% | 0.50% | -40.8% |
Q1 2021 | $4,572,000 | – | 450,000 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 1,551,521 | $13,498,233 | 4.40% |
Cormorant Asset Management, LP | 8,325,000 | $72,427,500 | 4.18% |
ORACLE INVESTMENT MANAGEMENT INC | 231,857 | $2,017,156 | 1.88% |
Finepoint Capital LP | 707,404 | $6,154,415 | 1.75% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,175,823 | $45,029,660 | 1.65% |
Octagon Capital Advisors LP | 1,093,503 | $9,513,476 | 1.50% |
TCG Crossover Management, LLC | 922,335 | $8,024,315 | 0.84% |
SUPERSTRING CAPITAL MANAGEMENT LP | 37,838 | $329,191 | 0.42% |
Corton Capital Inc. | 49,905 | $434,174 | 0.23% |
SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $870,000 | 0.20% |